Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Genetic interventions for vein bypass graft disease: a review.

Conte MS, Mann MJ, Simosa HF, Rhynhart KK, Mulligan RC.

J Vasc Surg. 2002 Nov;36(5):1040-52. Review.

PMID:
12422116
2.

Genetic therapy for vein bypass graft disease: current perspectives.

Simosa HF, Conte MS.

Vascular. 2004 Jul-Aug;12(4):213-7. Review.

PMID:
15704314
3.

Transcription factor decoys for the prevention of vein bypass graft failure.

Mann MJ, Conte MS.

Am J Cardiovasc Drugs. 2003;3(2):79-85. Review.

PMID:
14727934
4.

Molecular engineering of vein bypass grafts.

Conte MS.

J Vasc Surg. 2007 Jun;45 Suppl A:A74-81. Review.

5.

Gene therapy and coronary artery bypass grafting: current perspectives.

George SJ, Channon KM, Baker AH.

Curr Opin Mol Ther. 2006 Aug;8(4):288-94. Review.

PMID:
16955691
6.

Animal models for studying vein graft failure and therapeutic interventions.

Thomas AC.

Curr Opin Pharmacol. 2012 Apr;12(2):121-6. doi: 10.1016/j.coph.2012.01.002. Epub 2012 Jan 24. Review.

PMID:
22281067
7.

Gene therapy for the prevention of vein graft disease.

Southerland KW, Frazier SB, Bowles DE, Milano CA, Kontos CD.

Transl Res. 2013 Apr;161(4):321-38. doi: 10.1016/j.trsl.2012.12.003. Epub 2012 Dec 27. Review.

8.

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD000535. doi: 10.1002/14651858.CD000535.pub3. Review.

PMID:
25695213
9.

Interposition vein cuff for infragenicular prosthetic bypass graft.

Khalil AA, Boyd A, Griffiths G.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007921. doi: 10.1002/14651858.CD007921.pub2. Review.

PMID:
22972115
10.

Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.

Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH.

Ann Surg. 2013 May;257(5):824-33. doi: 10.1097/SLA.0b013e318288c38d. Review.

PMID:
23574989
11.

Revision of the failing vein graft: outcome of secondary operations.

Fujitani RM.

Semin Vasc Surg. 1993 Jun;6(2):118-29. Review.

PMID:
8252233
12.

Role of angioscopy in reoperation for the failing or failed infrainguinal vein bypass graft.

Hölzenbein TJ, Miller A, Tannenbaum GA, Contreras MA, Lavin PT, Gibbons GW, Campbell DR, Freeman DV, Pomposelli FB, LoGerfo FW.

Ann Vasc Surg. 1994 Jan;8(1):74-91. Review.

PMID:
8193004
13.

Arterial substitution in lower extremity trauma: autogenous vein vs polytetrafluoroethylene.

White WA, Smego DR, Barone JE.

Conn Med. 1992 Oct;56(10):525-8. Review.

PMID:
1458879
14.

A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.

Rychlik IJ, Davey P, Murphy J, O'Donnell ME.

J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. Review.

15.

Understanding and treating vein graft atherosclerosis.

Sarjeant JM, Rabinovitch M.

Cardiovasc Pathol. 2002 Sep-Oct;11(5):263-71. Review.

PMID:
12361836
16.

Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases.

Dardik H, Wengerter K, Qin F, Pangilinan A, Silvestri F, Wolodiger F, Kahn M, Sussman B, Ibrahim IM.

J Vasc Surg. 2002 Jan;35(1):64-71. Review.

17.

Applied gene therapy in preclinical models of vascular injury.

Janssens SP.

Curr Atheroscler Rep. 2003 May;5(3):186-90. Review.

PMID:
12667430

Supplemental Content

Support Center